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LETTER TO THE EDITOR
Serious complications associated with
regadenoson administration for myocardial
perfusion imaging
To the Editor,
The Editorial by Hage and Iskandrian1 regarding
‘‘Serious complications associated with regadenoson
administration for myocardial perfusion imaging:
A commentary’’ (September/October 2014 issue)
includes a table as a guide for serious complications
associated with regadenoson administration. In the table,
the authors reported whether or not each listed event
occurs with exercise and/or adenosine and that seizures
have not been reported with adenosine. Astellas has
received spontaneous post-marketing reports of seizures
in patients administered adenosine, and the package
insert for Adenoscan was updated in 2005 to reflect
these reports. The current package insert includes
‘‘seizure’’ in the Warnings section.2 In addition, there is
one published case report of bradyasystole and seizures
associated with the use of adenosine to terminate
supraventricular tachycardia.3 Astellas would like to
clarify that seizures can occur following the adminis-
tration of adenosine, and prescribers should be aware of
this risk and prepared to treat if necessary.2 The use of
methylxanthines (e.g., caffeine, aminophylline, and
theophylline) is not recommended in patients who
experience seizures in association with adenosine and
regadenoson.2
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